Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Total Liabilities and Share Holders Equity 2011-2025 | ZTS

Zoetis total liabilities and share holders equity from 2011 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Zoetis total liabilities and share holders equity for the quarter ending March 31, 2025 was $14.098B, a 1.74% decline year-over-year.
  • Zoetis total liabilities and share holders equity for 2024 was $14.237B, a 0.34% decline from 2023.
  • Zoetis total liabilities and share holders equity for 2023 was $14.286B, a 4.28% decline from 2022.
  • Zoetis total liabilities and share holders equity for 2022 was $14.925B, a 7.37% increase from 2021.
  
Zoetis Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $14,237
2023 $14,286
2022 $14,925
2021 $13,900
2020 $13,609
2019 $11,545
2018 $10,777
2017 $8,586
2016 $7,649
2015 $7,913
2014 $6,588
2013 $6,558
2012 $6,262
2011 $5,711
2010 $0
Zoetis Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2025-03-31 $14,098
2024-12-31 $14,237
2024-09-30 $14,357
2024-06-30 $14,165
2024-03-31 $14,348
2023-12-31 $14,286
2023-09-30 $14,106
2023-06-30 $13,749
2023-03-31 $13,754
2022-12-31 $14,925
2022-09-30 $13,674
2022-06-30 $13,770
2022-03-31 $13,860
2021-12-31 $13,900
2021-09-30 $13,705
2021-06-30 $14,069
2021-03-31 $13,796
2020-12-31 $13,609
2020-09-30 $13,725
2020-06-30 $13,069
2020-03-31 $11,528
2019-12-31 $11,545
2019-09-30 $11,272
2019-06-30 $10,986
2019-03-31 $10,883
2018-12-31 $10,777
2018-09-30 $10,459
2018-06-30 $8,603
2018-03-31 $8,690
2017-12-31 $8,586
2017-09-30 $9,288
2017-06-30 $7,802
2017-03-31 $7,649
2016-12-31 $7,649
2016-09-30 $7,715
2016-06-30 $7,518
2016-03-31 $7,453
2015-12-31 $7,913
2015-09-30 $6,686
2015-06-30 $6,598
2015-03-31 $6,430
2014-12-31 $6,588
2014-09-30 $6,527
2014-06-30 $6,522
2014-03-31 $6,403
2013-12-31 $6,558
2013-09-30 $6,259
2013-06-30 $6,261
2013-03-31 $6,142
2012-12-31 $6,262
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $5,711
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $67.725B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.321B 31.28
Daiichi Sankyo, - (DSNKY) Japan $46.412B 23.79
Takeda Pharmaceutical (TAK) Japan $46.074B 9.16
BeOne Medicines - (ONC) Cayman Islands $31.945B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.145B 0.00
Summit Therapeutics (SMMT) United States $21.292B 0.00
Merck (MKKGY) Germany $17.234B 12.63
Shionogi (SGIOY) Japan $14.649B 14.68
United Therapeutics (UTHR) United States $13.735B 12.15
Neurocrine Biosciences (NBIX) United States $13.077B 44.79
Orion OYJ (ORINY) Finland $11.714B 28.23
IPSEN (IPSEY) France $10.870B 0.00
Stevanato Group S.p.A (STVN) Italy $8.028B 49.09
Corcept Therapeutics (CORT) United States $7.242B 58.87
Grifols, S.A (GRFS) Spain $6.944B 0.00
Ionis Pharmaceuticals (IONS) United States $6.724B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.625B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.204B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.358B 0.00
Hypermarcas (HYPMY) Brazil $2.945B 19.38
Crinetics Pharmaceuticals (CRNX) United States $2.902B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.650B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.558B 8.96
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.526B 13.66
Centessa Pharmaceuticals (CNTA) United Kingdom $2.058B 0.00
Ocular Therapeutix (OCUL) United States $1.945B 0.00
Endo (NDOI) United States $1.812B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.789B 0.00
ARS Pharmaceuticals (SPRY) United States $1.755B 0.00
Evotec AG (EVO) Germany $1.513B 0.00
Harrow (HROW) United States $1.328B 0.00
Guardian Pharmacy Services (GRDN) United States $1.301B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.206B 24.14
Dyne Therapeutics (DYN) United States $1.131B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.067B 0.00
Enliven Therapeutics (ELVN) United States $1.040B 0.00
Ardelyx (ARDX) United States $1.026B 0.00
Collegium Pharmaceutical (COLL) United States $1.021B 5.51
Verve Therapeutics (VERV) United States $0.992B 0.00
ProKidney (PROK) United States $0.963B 0.00
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Cronos Group (CRON) Canada $0.791B 0.00
Xeris Biopharma Holdings (XERS) United States $0.785B 0.00
KalVista Pharmaceuticals (KALV) United States $0.728B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.727B 0.00
Xencor (XNCR) United States $0.658B 0.00
Relay Therapeutics (RLAY) United States $0.641B 0.00
Organogenesis (ORGO) United States $0.638B 0.00
Zevra Therapeutics (ZVRA) United States $0.614B 0.00
USANA Health Sciences (USNA) United States $0.595B 11.97
Elite Pharmaceuticals (ELTP) United States $0.591B 0.00
Theravance Biopharma (TBPH) United States $0.552B 0.00
Bioventus (BVS) United States $0.540B 13.69
Oruka Therapeutics (ORKA) United States $0.534B 0.00
Siga Technologies (SIGA) United States $0.510B 10.66
Tourmaline Bio (TRML) United States $0.508B 0.00
Savara (SVRA) United States $0.446B 0.00
Aquestive Therapeutics (AQST) United States $0.412B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.366B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.360B 9.74
AleAnna (ANNA) United States $0.332B 0.00
Altimmune (ALT) United States $0.331B 0.00
Nanobiotix S.A (NBTX) France $0.321B 0.00
Nektar Therapeutics (NKTR) United States $0.310B 0.00
Aldeyra Therapeutics (ALDX) United States $0.310B 0.00
Esperion Therapeutics (ESPR) United States $0.299B 0.00
Heron Therapeutics (HRTX) United States $0.291B 0.00
Nature's Sunshine Products (NATR) United States $0.272B 24.93
OmniAb (OABI) United States $0.256B 0.00
Larimar Therapeutics (LRMR) United States $0.248B 0.00
Liminatus Pharma (LIMN) United States $0.227B 0.00
MediWound (MDWD) Israel $0.220B 0.00
4D Molecular Therapeutics (FDMT) United States $0.212B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Galectin Therapeutics (GALT) United States $0.184B 0.00
Aclaris Therapeutics (ACRS) United States $0.184B 0.00
Lyell Immunopharma (LYEL) United States $0.184B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.132B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
Cassava Sciences (SAVA) United States $0.114B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
Nutriband (NTRB) United States $0.095B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
VAXART, INC (VXRT) United States $0.092B 0.00
Metagenomi (MGX) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.086B 19.50
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
Surrozen (SRZN) United States $0.077B 0.00
Inotiv (NOTV) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.075B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.072B 0.00
Assertio Holdings (ASRT) United States $0.071B 0.00
Wellgistics Health (WGRX) United States $0.068B 0.00
Telomir Pharmaceuticals (TELO) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.061B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
Klotho Neurosciences (KLTO) United States $0.057B 0.00
Century Therapeutics (IPSC) United States $0.054B 0.00
Jupiter Neurosciences (JUNS) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.053B 39.06
Prelude Therapeutics (PRLD) United States $0.053B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Acrivon Therapeutics (ACRV) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
Vivos Therapeutics (VVOS) United States $0.031B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Cosmos Health (COSM) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
DURECT (DRRX) United States $0.018B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.013B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Aptorum Group (APM) United Kingdom $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 10.02
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.60
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00